Weight loss pills are finally here — and they actually work

For years, the most effective weight loss medications came in one form: a needle. That's no longer the case. Two brand-new GLP-1 pills have just received FDA approval, and the results from clinical trials are genuinely impressive.

As a physician specializing in obesity medicine, I've had patients tell me the same thing over and over: "I want help with my weight, but I don't want injections." Whether it's needle anxiety, lifestyle logistics or simply personal preference — that barrier has kept far too many people from accessing life-changing treatment.

That barrier just got a lot smaller. Here's what you need to know about the two newest options on the market.

Option 1: The Wegovy Pill (Oral Semaglutide)

In December 2025, the FDA approved the first-ever oral GLP-1 medication specifically for weight loss, the Wegovy pill, made by Novo Nordisk. It became available in pharmacies across the U.S. in early January 2026.

If you've heard of Ozempic or Wegovy injections, you already know the active ingredient: semaglutide. This pill contains the same molecule, just taken orally at a 25 mg dose. It works by mimicking the gut hormone GLP-1, which signals your brain to feel full sooner and eat less over time.

These results come from the OASIS 4 phase 3 clinical trial, which followed more than 300 adults with obesity or overweight for 64 weeks. The level of weight loss achieved was comparable to that of the injectable Wegovy — a meaningful milestone for oral medicine.

Option 2: Foundayo (Orforglipron)

Just weeks ago, on April 1, 2026, the FDA approved a second GLP-1 pill for weight loss: Foundayo (orforglipron), made by Eli Lilly, the same company behind the Mounjaro and Zepbound injections. It became available via pharmacy beginning April 6th.

What makes Foundayo scientifically unique is that it's a small-molecule, non-peptide GLP-1 receptor agonist. In plain terms: it's chemically different from semaglutide-based drugs, and that difference has a major practical benefit — you can take it anytime of day, with or without food and water.

The ATTAIN-1 trial, which enrolled over 3,100 adults across multiple countries, also showed meaningful improvements in blood pressure, cholesterol, and waist circumference. For patients with prediabetes, up to 91% of those on orforglipron achieved near-normal blood sugar levels by 72 weeks.

Pills vs. Injections: How do they stack up?

You may be wondering: if injections like Wegovy and Zepbound are already available, why does this matter? Here's an honest, side-by-side comparison so you can see how all the options relate.

What my patients should keep in mind

I want to be transparent with you, because that's what good medicine looks like. Here are a few things worth understanding before you start asking about these medications:

Results still vary from person to person

Clinical trial averages are powerful, but they're averages. Some patients lose significantly more, others less. Your starting weight, metabolic health, diet, activity level, and consistency with the medication all play a role. These are tools — not magic. They work best alongside real lifestyle change.

Side effects are real, but usually manageable

Both new pills carry the same category of side effects as injectable GLP-1s: nausea, diarrhea, vomiting, and stomach discomfort — especially during dose escalation. These typically improve over time. The key is a slow, supervised titration schedule, which is exactly how we manage it at our clinic.

The Wegovy pill has dosing requirements you need to follow

This one matters for efficacy. The Wegovy pill must be taken on an empty stomach, with only a small sip of plain water, and you need to wait at least 30 minutes before eating or drinking anything else. Skipping this step affects how the medication is absorbed. If this routine is difficult for you, Foundayo — which has no such restrictions — may be a better fit.

Not everyone is a candidate

Both medications carry a boxed warning for thyroid C-cell tumors and are contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia type 2 (MEN 2). They are also not approved for use during pregnancy. A proper medical evaluation is essential before starting any GLP-1 therapy.

Injectable GLP-1s may still be the better option for some patients

If you need maximum weight loss — especially if you're managing significant obesity-related health conditions like severe sleep apnea, orthopedic issues, or cardiovascular disease — the injectable tirzepatide (Zepbound) still leads in clinical efficacy. We always choose the right tool for the right patient.

Interested in personalized weight-loss treatment?

If you’re ready to explore advanced, evidence-based options for weight management—including GLP-1 medications, lifestyle coaching, and metabolic testing—schedule a consultation today.

📍 Get Healthy Medicine
Located inside Lake Nona Performance Center
Serving patients across Florida via telemedicine

👉 Book an Appointment
📞 Call us today or visit GetHealthyMed.com